Home » BARR CONFIRMS SAVIENT PATENT CHALLENGE
BARR CONFIRMS SAVIENT PATENT CHALLENGE
Barr Pharmaceuticals Inc. confirmed Wednesday it is challenging the patents protecting Savient Pharmaceuticals Inc.'s Oxandrin CIII weight gain treatment.
MSN Money (http://news.moneycentral.msn.com/provider/providerarticle.asp?feed=AP&Date=20060927&ID=6057244)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct